Kingsten Lin

Jul 23, 2024 | biorxiv.org | Yuxin Yang |Feixiong Cheng |Kingsten Lin

AbstractThe continued growth of antibiotic resistance and the slowing of antibiotic discovery poses a large challenge in fighting infectious diseases. Recent advances in Artificial intelligence (AI) technologies offer a time- and cost-effective solution for the rapid development of effective antibiotics. In this study, we presented an explainable AI framework from a pre-trained model using 10 million drug-like molecular images.